IP Library Granted Patent US 8,871,521
Granted Patent B2
US 8,871,521 · App. 13/415,624 · Granted Oct 28, 2014

Breath ketone detector

Inventor: Raymond F. Akers, Jr. (Sewell, NJ)
Assignee: Akers Biosciences, Inc.
G01N33/52G01N33/6893G01N33/18B01L2200/16G01N2800/18G01N2800/02B01L2300/0835B01L2300/0832G01N33/1826
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,871,521
App. No.
13/415,624
Granted
Oct 28, 2014
Kind
B2
Abstract

Ketoacidosis is an extreme and uncontrolled form of ketosis, which is a normal response to prolonged fasting. Embodiments of this invention test the ketone level of a patient by measuring the ketone bodies in breath condensation. Some embodiments include a device for medical testing comprising a hollow container, comprising powder mixture of sodium nitroferricyanide, ammonium sulfate and silica and a liquid including an ammonium hydroxide solution.

Claims (40)

1. A device for medical testing for the presence of ketones in breath of a patient, comprising a hollow container, the hollow container containing:

a powder comprising

a powder reagent selected from the group consisting of sodium nitroferricyanide, dinitrophenyihydrazine, copper sulfate/potassium sodium tartrate, and combinations of any thereof; and

a powder component selected from the group consisting of sodium silicate, calcium sulfate, calcium chloride, montmorillonite clay, molecular sieves, phosphorous pentoxide, silica, cellulose, glass beads, poly(2,6-diphenylphenylene oxide polymer and combinations of any thereof; and

a liquid reagent solution comprising a strong base selected from the group consisting of an alkali hydroxide, an alkaline-earth metal hydroxide, and a combination of any thereof,

wherein the hollow container is configured such that the breath comes in contact with the powder after the patient blows into the hollow container, and the powder changes color upon exposure to the ketones and the liquid reagent solution.

2. The device of claim 1 , wherein the powder further comprises ammonium sulfate.

3. The device of claim 2 , wherein the powder further comprises a third powder component selected from the group consisting of glycine, lactose, disodium hydrogen phosphate, and combinations of any thereof.

4. The device of claim 1 , wherein the powder comprises sodium nitroferricyanide in an amount of 0.36 mg to 36 mg, 20/50 grade silica in the amount of 10 mg to 1 g, and ammonium sulfate in an amount of 9.64 mg to 964 mg; and the liquid reagent solution comprises ammonium hydroxide in an amount of 50 μL to 2000 μL of 15% to 30% aqueous solution.

5. The device of claim 1 , wherein the powder is contained in a first ampoule, the liquid reagent solution is contained in a second ampoule, and the first and second ampoules are contained within the hollow container.

6. A method for testing for presence of ketones in breath of a patient using the device of claim 1 , comprising:

exposing the powder to the breath of the patient;

contacting the powder with the liquid reagent solution to form a mixture; and

evaluating color of the mixture.

7. A device for medical testing for the presence of ketones in breath of a patient, comprising a first ampoule and a second ampoule, wherein

the first and second ampoules are contained within a hollow container;

the first ampoule contains a powder comprising about 3.6 mg sodium nitroferricyanide, about 100 mg 20/50 grade silica, and about 96.4 mg ammonium sulfate; and

the second ampoule contains a liquid reagent solution comprising about 500 μL of about 22% ammonium hydroxide aqueous solution,

wherein the hollow container is configured such that the breath comes in contact with the powder after the patient blows into the hollow container, and the powder changes color upon exposure to the ketones and the liquid reagent solution.

8. A method for testing for presence of ketones in breath of a patient using the device of claim 7 , comprising:

breaking the first ampoule;

exposing the powder to the breath by the patient blowing into the hollow container;

breaking the second ampoule;

contacting the powder with the liquid reagent solution to form a mixture; and

evaluating the color of the mixture.

9. A method for testing for presence of ketones in breath of a patient, comprising:

exposing a powder to the breath of the patient by the patient blowing into a hollow container containing the powder, wherein the powder comprises

a powder reagent selected from the group consisting of sodium nitroferricyanide, dinitrophenylhydrazine, copper sulfate/potassium sodium tartrate, and combinations of any thereof; and

a powder component selected from the group consisting of sodium silicate, calcium sulfate, calcium chloride, montmorillonite clay, molecular sieves, phosphorous pentoxide, silica, cellulose, glass beads, poly(2,6-diphenylphenylene oxide polymer and combinations of any thereof;

contacting the powder with a liquid reagent solution to form a mixture, wherein the liquid reagent comprises a strong base selected from the group consisting of an alkali hydroxide, an alkaline-earth metal hydroxide, and a combination of any thereof; and

evaluating color of the mixture.

10. The method of claim 9 , wherein the powder is contained in a first ampoule, the liquid reagent solution is contained in a second ampoule, and wherein the first and second ampoules are contained within a hollow container.

11. The method of claim 10 , further comprising:

breaking the first ampoule before exposing the powder to the breath, wherein exposing the powder to the breath comprises the patient blowing into the hollow container; and

breaking the second ampoule before contacting the powder with the liquid reagent solution.

12. The method of claim 9 , wherein evaluating color of the mixture comprises comparing the color of the mixture to at least one reference color.

13. The method of claim 9 , wherein the powder further comprises ammonium sulfate and silica.

14. The method of claim 13 , wherein the powder comprises sodium nitroferricyanide in an amount of 0.36 mg to 36 mg, 20/50 grade silica in an amount of 10 mg to 1 g, and ammonium sulfate in an amount of 9.64 mg to 964 mg; and the liquid reagent solution comprises ammonium hydroxide in an amount of 50 μL to 2000 μL of 15% to 30% aqueous solution.

15. The device of claim 1 , wherein the strong base is selected from the group consisting of ammonium hydroxide, lithium hydroxide, sodium hydroxide, potassium hydroxide, rubidium hydroxide, cesium hydroxide, calcium hydroxide, strontium hydroxide, barium hydroxide, and combinations thereof.

16. The method of claim 9 , wherein the strong base is selected from the group consisting of ammonium hydroxide, lithium hydroxide, sodium hydroxide, potassium hydroxide, rubidium hydroxide, cesium hydroxide, calcium hydroxide, strontium hydroxide, barium hydroxide, and combinations thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 11, 2012
From: AKERS, RAYMOND F., JR.
To: AKERS BIOSCIENCES, INC.
Reel/Frame 028195/0221 →
Continuity (2)
Provisional Application 61450396 · Mar 8, 2011
Related Publication 20120231548A1 · Sep 13, 2012